Jobs / United States / Gilead Sciences INC
Director, Clinical Development
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles1 certified filing for “Associate Clinical Pharmacology Director” (Natural Sciences Managers) in NJ: $184k–$184k, median $184k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description JOB DESCRIPTION: • You will support or lead multiple components of clinical trial programs in Inflammation/Fibrosis clinical development, including primary biliary cholangitis (PBC) or other liver disease indications with potential for opportunities across the Inflammation therapeutic area at Gilead. • Responsibilities may include clinical study design; protocol preparation; support for successful study start-up, maintenance, or close out; conduct or oversight of data cleaning to ensure high quality analyses; conduct or oversight of medical monitoring; contributions to data analysis plans and clinical study report drafting; providing clinical development input into regulatory documents or health authority interactions; leading efforts on publications and scientific communication of study results; thought leader engagement and representing Gilead among external stakeholders; providing clinical and scientific leadership on cross-functional teams. • Stage of studies to which you may be assigned include Phase 2, Phase 3, and Phase 4, with potential for earlier phase work as well. This is an opportunity for exposure and leadership across a range of clinical development activities. The ideal candidate will have strong scientific acumen, interest in learning across new indications, passion for collaboration and teamwork in a fast-paced environment, and excellent communication skills. EXAMPLE RESPONSIBILITIES: • Provide or oversee medical monitoring for clinical trials • Provide input into, or lead, clinical trial protocol strategy, design, and content • Support successful study start-up, maintenance, and/or closeout • Present at clinical study investigator meetings and represent Gilead in interactions with investigators in other settings • Serve as clinical reviewer of data listings for data cleaning, ensuring accurate and complete data to support high-quality analyses • Collaboration with Biostats on analysis planning and generation of study results • Provide input into, or lead, clinical study report content and responses to health authority inquiries • Provide input into the Target Product Profile and support, or lead, creation of the Clinical Development Plan for assigned molecules /products • Provide scientific and clinical guidance to cross-functional teams and colleagues to meet clinical development project deliverables and timelines • Lead the clinical development component(s) in the preparation/review of investigator brochures or other regulatory documents • Lead scientific communication of data through scientific conference abstract submissions and through manuscri